APTIVUS Side Effects

6984729-7 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
on Sep 10, 2010 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (800 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6827272-8 | Cachexia
Patient was taking Aptivus (View Usage). Patient had the following side effects: cachexia on Jul 07, 2010 from Additional patient health information: Female patient , 28 years of age, was diagnosed with acquired immunodeficiency syndrome and. Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), KIVEXA (1 Tablet Daily) (View Kivexa Review and Kivexa Label ).

6827198-X | Cachexia, Lymphadenopathy
Adverse event was reported on Jul 07, 2010 by a Male patient taking Aptivus (View Usage) (Dosage: 2 Capsules Daily) was diagnosed with acquired immunodeficiency syndrome and. Location: , 41 years of age, After Aptivus was administered, patient had the following side effects: cachexia, lymphadenopathy. During the same period patient was treated with RITONAVIR (1 Tablet Once A Day) (View Ritonavir Review and Ritonavir Label ), TRUVADA (2 Capsules Once A Day) (View Truvada Review and Truvada Label ).

6826941-3 |
on Jul 07, 2010 Female patient from , 46 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Aptivus (View Usage). . Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), KIVEXA (1 Tablet Daily) (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ), KALETRA (View Kaletra Review and Kaletra Label ).


6826781-5 | Cachexia, Lymphadenopathy
on Jul 07, 2010 Male patient from , 34 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Aptivus (View Usage). Patient had the following side effects: cachexia, lymphadenopathy. Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), KIVEXA (1 Tablet Daily) (View Kivexa Review and Kivexa Label ).

6826601-9 | Cachexia, Candidiasis
Patient was taking Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: cachexia, candidiasis on Jul 07, 2010 from Additional patient health information: Male patient , 44 years of age, was diagnosed with acquired immunodeficiency syndrome and. Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), TRUVADA (1 Tablet Daily) (View Truvada Review and Truvada Label ).

6826566-X | Cachexia, Hepatomegaly, Nausea
Adverse event was reported on Jul 07, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 2 Capsules Daily) was diagnosed with acquired immunodeficiency syndrome and. Location: , 25 years of age, Patient experienced the following unwanted or unexpected effects: cachexia, hepatomegaly, nausea (What is nausea?). During the same period patient was treated with RITONAVIR (2 Capsules Once A Day) (View Ritonavir Review and Ritonavir Label ), KIVEXA (1 Tablet Once A Day) (View Kivexa Review and Kivexa Label ).

6826560-9 | Cachexia, Gastroenteritis
on Jul 07, 2010 Male patient from , 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Aptivus (View Usage). Patient had the following side effects: cachexia, gastroenteritis (What is gastroenteritis?). Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), TRUVADA (One Tablet Daily) (View Truvada Review and Truvada Label ).

6826468-9 | Cachexia, Diarrhoea, Malnutrition
on Jul 07, 2010 Male patient from , 41 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: cachexia, diarrhoea, malnutrition. Aptivus dosage: 2 Capsules Daily. During the same period patient was treated with RITONAVIR (2 Capsules Daily) (View Ritonavir Review and Ritonavir Label ), TRUVADA (1 Tablet Daily) (View Truvada Review and Truvada Label ).

6716192-5 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Patient was taking Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition on May 04, 2010 from Additional patient health information: Male patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6716191-3 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Adverse event was reported on May 04, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 28 years of age, Patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6716190-1 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on May 04, 2010 Female patient from , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6716011-7 | Bilirubin Conjugated Abnormal, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on May 04, 2010 Female patient from , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated abnormal, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6714402-1 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Patient was taking Aptivus (View Usage). Patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition on May 04, 2010 from Additional patient health information: Male patient , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6714207-1 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Adverse event was reported on May 04, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 46 years of age, After Aptivus was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6714151-X | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on May 04, 2010 Male patient from , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6714092-8 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on May 04, 2010 Male patient from , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). Patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688423-1 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Patient was taking Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition on Apr 16, 2010 from Additional patient health information: Female patient , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688422-X | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Adverse event was reported on Apr 16, 2010 by a Male patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 41 years of age, Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688421-8 | Bilirubin Conjugated Abnormal, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on Apr 16, 2010 Female patient from , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). Patient had the following side effects: bilirubin conjugated abnormal, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688420-6 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on Apr 16, 2010 Female patient from , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (Not Reported) (View Ritonavir Review and Ritonavir Label ), KIVEXA (Not Reported) (View Kivexa Review and Kivexa Label ), TRUVADA (Not Reported) (View Truvada Review and Truvada Label ).

6688419-X | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Patient was taking Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition on Apr 16, 2010 from Additional patient health information: Male patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688345-6 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
Adverse event was reported on Apr 16, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 46 years of age, Patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (Not Reported) (View Kivexa Review and Kivexa Label ), TRUVADA (Not Reported) (View Truvada Review and Truvada Label ).

6688344-4 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on Apr 16, 2010 Male patient from , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6688086-5 | Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Cachexia, Diarrhoea, Malnutrition
on Apr 16, 2010 Male patient from , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, cachexia, diarrhoea, malnutrition. Aptivus dosage: 1000 Mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), TRUVADA (View Truvada Review and Truvada Label ).

6637069-X | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Patient was taking Aptivus (View Usage). Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous on Mar 11, 2010 from Additional patient health information: Female patient , weighting 4.85 lb, was diagnosed with gestational diabetes and. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (800 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6633407-2 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Adverse event was reported on Mar 08, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with gestational diabetes and. Location: , weighting 4.85 lb, After Aptivus was administered, patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6633406-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis, Premature Labour
on Feb 26, 2010 Female patient from , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?), premature labour. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (Once Daily) (View Truvada Review and Truvada Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6633405-9 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
on Feb 26, 2010 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6590430-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis, Premature Labour
Patient was taking Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?), premature labour on Feb 05, 2010 from Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (Once Daily) (View Truvada Review and Truvada Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6577983-7 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Adverse event was reported on Feb 05, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with gestational diabetes and. Location: , weighting 4.85 lb, Patient experienced the following unwanted or unexpected effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6567962-8 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
on Jan 20, 2010 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6567771-X | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
on Jan 20, 2010 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6567756-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis, Premature Labour
Patient was taking Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?), premature labour on Jan 20, 2010 from Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (Once Daily) (View Truvada Review and Truvada Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6538999-X | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Adverse event was reported on Jan 11, 2010 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) . Location: , weighting 4.85 lb, Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ). Patient was hospitalized and became disabled.

6538898-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis, Premature Labour
on Jan 08, 2010 Female patient from , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?), premature labour. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (Once Daily) (View Truvada Review and Truvada Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), INSULIN (View Insulin Review and Insulin Label ), NOVORAPID (View Novorapid Review and Novorapid Label ).

6534528-5 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
on Jan 08, 2010 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized and became disabled.

6532931-0 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Patient was taking Aptivus (View Usage). Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous on Jan 04, 2010 from Additional patient health information: Female patient , weighting 4.85 lb, was diagnosed with gestational diabetes and. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6528933-0 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Erythema, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous
Adverse event was reported on Dec 31, 2009 by a Female patient taking Aptivus (View Usage) (Dosage: 1000 Mg) was diagnosed with gestational diabetes and. Location: , weighting 4.85 lb, After Aptivus was administered, patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, erythema, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (1000 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6497860-X | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous, Lipodystrophy Acquired
on Dec 10, 2009 Female patient from , weighting 4.85 lb, was diagnosed with gestational diabetes and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous, lipodystrophy acquired. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (400 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (200 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6467772-6 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous, Lipodystrophy Acquired
on Nov 25, 2009 Female patient from , weighting 4.85 lb, was treated with Aptivus (View Usage). Patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous, lipodystrophy acquired. Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (400 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (400 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (200 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

6453127-7 | Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Musculoskeletal Anomaly, Exomphalos, Gastrointestinal Disorder Congenital, Genitalia External Ambiguous, Lipodystrophy Acquired
Patient was taking Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital musculoskeletal anomaly, exomphalos, gastrointestinal disorder congenital, genitalia external ambiguous, lipodystrophy acquired on Nov 17, 2009 from Additional patient health information: Female patient , weighting 4.85 lb, . Aptivus dosage: 1000 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (200 Mg) (View Ritonavir Review and Ritonavir Label ), ETRAVIRINE (400 Mg) (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (800 Mg) (View Raltegravir Review and Raltegravir Label ), PREZISTA (1200 Mg) (View Prezista Review and Prezista Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

6336786-9 | Asthenia, Dizziness, Dyspnoea, Hypophagia
Adverse event was reported on Aug 31, 2009 by a Male patient taking Aptivus (View Usage) (Dosage: 2 Tablet Twice Daily Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 41 years of age, weighting 190.9 lb, Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), dyspnoea, hypophagia. During the same period patient was treated with NORVIR (1 Tablet Once Daily Po) (View Norvir Review and Norvir Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), EMTRICITABINE/TENOFOVIR (View Emtricitabine/tenofovir Review and Emtricitabine/tenofovir Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ... (View ... Review and ... Label ). Patient was hospitalized.

6111963-0 | Abdominal Distension, Asthenia, Fatigue
on Feb 26, 2009 Female patient from , 47 years of age, was treated with Aptivus (View Usage). Patient had the following side effects: abdominal distension, asthenia, fatigue. Aptivus dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ).

6012537-2 | Cholecystitis, Gallbladder Disorder
on Dec 11, 2008 Male patient from , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), hyperkeratosis, diarrhoea, herpes virus infection, dyslipidaemia, onychomycosis and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: cholecystitis, gallbladder disorder. Aptivus dosage: Tpv/rtv 500/200mg. During the same period patient was treated with DIPROSALIC (View Diprosalic Review and Diprosalic Label ), IMODIUM (View Imodium Review and Imodium Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), CRESTOR (10mg) (View Crestor Review and Crestor Label ), LAMISIL (250mg) (View Lamisil Review and Lamisil Label ), VIDEX (250mg) (View Videx Review and Videx Label ), KIVEXA (One Daily) (View Kivexa Review and Kivexa Label ). Patient was hospitalized.

6004754-2 | Ascites, Escherichia Bacteraemia, Hepatic Cirrhosis, Hypothermia
Patient was taking Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, escherichia bacteraemia, hepatic cirrhosis, hypothermia (What is hypothermia?) on Dec 01, 2008 from Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Aptivus dosage: Tpv/rtv: 500/200 Mg B.i.d.. During the same period patient was treated with FUZEON (180mg) (View Fuzeon Review and Fuzeon Label ), EMTRIVA (200mg) (View Emtriva Review and Emtriva Label ), VIREAD (245mg) (View Viread Review and Viread Label ). Patient was hospitalized.

6004733-5 | Haematoma, Haemorrhage Intracranial
Adverse event was reported on Dec 01, 2008 by a Male patient taking Aptivus (View Usage) (Dosage: Tpv: 500mg B.i.d. / Rtv: 100 Mg Every 36 Hours) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 41 years of age, weighting 130.1 lb, Patient had the following side effects: haematoma, haemorrhage intracranial. During the same period patient was treated with LOVENOX (20mg) (View Lovenox Review and Lovenox Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), MEDROL (View Medrol Review and Medrol Label ), NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), VIREAD (245mg) (View Viread Review and Viread Label ), FUZEON (180mg) (View Fuzeon Review and Fuzeon Label ).

5922810-1 | Aids Dementia Complex, Central Nervous System Inflammation, Cerebellar Ataxia, Encephalitis Viral, Grand Mal Convulsion, Immune Reconstitution Syndrome, Viral Load Increased
on Oct 15, 2008 Male patient from , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Aptivus (View Usage). After Aptivus was administered, patient had the following side effects: aids dementia complex, central nervous system inflammation, cerebellar ataxia, encephalitis viral, grand mal convulsion, immune reconstitution syndrome, viral load increased. Aptivus dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ). Patient was hospitalized.

5916926-3 | Cholecystitis
on Sep 30, 2008 Male patient from , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), hyperkeratosis, diarrhoea, herpes virus infection, hypertriglyceridaemia, dyspepsia and was treated with Aptivus (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis. Aptivus dosage: Tpv/rtv 500/200mg. During the same period patient was treated with DIPROSALIC (View Diprosalic Review and Diprosalic Label ), IMODIUM (View Imodium Review and Imodium Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), CRESTOR (View Crestor Review and Crestor Label ), LAMISIL (View Lamisil Review and Lamisil Label ), DUSPATALIN (View Duspatalin Review and Duspatalin Label ). Patient was hospitalized.

5909387-1 | Cholecystitis
Patient was taking Aptivus (View Usage). Patient had the following side effects: cholecystitis on Sep 22, 2008 from Additional patient health information: Male patient , weighting 163.1 lb, . Aptivus dosage: . Patient was hospitalized.